The Latest Breaking News from the US Food and Drug Administration

Brominated vegetable oil is a food additive that studies show causes organ damage in rats and pigs. It was introduced in the 1920s and is used today in sodas and sports drinks.

An advisory panel of the US Food and Drug Administration has found that a drug used in the majority of cold and flu products to treat blocked noses does not work.

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

A report released by a tech watchdog group says TikTok has become a key marketing channel for vendors that want to promote steroids and other bodybuilding drugs to millions of the app's users

Prime drinks have become a Gen Z status symbol, a prized social media prop for a certain brand of teen male. But they're causing jitters among pediatricians who say they pack scary caffeine levels.

The pharma sector is poised to witness significant growth due to the widespread adoption of generic medicines and emerging technologies. Therefore, fundamentally strong pharma stocks Pfizer (PFE), Sanofi (SNY), and Spero Therapeutics (SPRO) might be solid buys. Read on.

The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.

With measures to protect abortion access becoming law in two states, a ban in a third state and court action elsewhere, the status of abortion law in the U.S. remains unsettled

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic.

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…